-
公开(公告)号:US20250084470A1
公开(公告)日:2025-03-13
申请号:US18896256
申请日:2024-09-25
Applicant: Life Technologies Corporation
Inventor: Rajesh Gottimukkala , Amir Marcovitz , Jeoffrey Schageman , Varun Bagai , Jian Gu , James Veitch , Kelli Bramlett , Scott Myrand , Fiona Hyland , Seth Sadis , Paul Williams
IPC: C12Q1/6851 , G06F17/18 , G16B25/10
Abstract: A method for detecting a gene fusion includes amplifying a nucleic acid sample in the presence of primer pool to produce a plurality of amplicons. The primer pool includes primers targeting a plurality of exon-exon junctions of a driver gene. The amplicons correspond to the exon-exon junctions. The amplicons are sequenced and aligned to a reference sequence. The number of reads corresponding to each amplicon is normalized to give a normalized read count. A baseline correction is applied to the normalized read counts for the amplicons to form corrected read counts. A binary segmentation score is calculated for each corrected read count. A predicted breakpoint for the gene fusion is determined based on the amplicon index corresponding to the maximum absolute binary segmentation score. Gene fusion events may be detected in a partner agnostic manner, i.e. without prior knowledge of the specific fusion partner genes or specific breakpoint information.
-
公开(公告)号:US12139753B2
公开(公告)日:2024-11-12
申请号:US16825238
申请日:2020-03-20
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Rajesh Gottimukkala , Amir Marcovitz , Jeoffrey Schageman , Varun Bagai , Jian Gu , James Veitch , Kelli Bramlett , Scott Myrand , Fiona Hyland , Seth Sadis , Paul Williams
IPC: C12Q1/68 , C12Q1/6851 , G06F17/18 , G16B25/10
Abstract: A method for detecting a gene fusion includes amplifying a nucleic acid sample in the presence of primer pool to produce a plurality of amplicons. The primer pool includes primers targeting a plurality of exon-exon junctions of a driver gene. The amplicons correspond to the exon-exon junctions. The amplicons are sequenced and aligned to a reference sequence. The number of reads corresponding to each amplicon is normalized to give a normalized read count. A baseline correction is applied to the normalized read counts for the amplicons to form corrected read counts. A binary segmentation score is calculated for each corrected read count. A predicted breakpoint for the gene fusion is determined based on the amplicon index corresponding to the maximum absolute binary segmentation score. Gene fusion events may be detected in a partner agnostic manner, i.e. without prior knowledge of the specific fusion partner genes or specific breakpoint information.
-
公开(公告)号:US09777333B2
公开(公告)日:2017-10-03
申请号:US14244824
申请日:2014-04-03
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Daniel Rhodes , Seth Sadis , Peter Wyngaard , Armand Bankhead , Dinesh Cyanam , Nikolay Khazanov
CPC classification number: C12Q1/6886 , C12Q2600/156
Abstract: The disclosure provides gene fusion variants and novel associations with disease states, as well as kits, probes, and methods of using the same.
-
公开(公告)号:US10072298B2
公开(公告)日:2018-09-11
申请号:US14672066
申请日:2015-03-27
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Daniel Rhodes , Seth Sadis , Peter Wyngaard , Nikolay Khazanov , Santhoshi Bandla , Mark Tomilo , Sean Eddy , Emma Bowden , Jia Li
IPC: C12Q1/6886 , G06F19/18 , G06F19/22 , G06F19/24
CPC classification number: C12Q1/6886 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16 , G16B20/00 , G16B30/00 , G16B40/00
Abstract: The disclosure provides gene fusions, gene variants, and novel associations with disease states, as well as kits, probes, and methods of using the same.
-
公开(公告)号:US20140323329A1
公开(公告)日:2014-10-30
申请号:US14244824
申请日:2014-04-03
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Daniel RHODES , Seth Sadis , Peter Wyngaard , Armand Bankhead , Dinesh Cyanam , Nikolay Khazanov
IPC: C12Q1/68
CPC classification number: C12Q1/6886 , C12Q2600/156
Abstract: The disclosure provides gene fusion variants and novel associations with disease states, as well as kits, probes, and methods of using the same.
Abstract translation: 本公开提供了基因融合变体和与疾病状态的新型关联,以及试剂盒,探针及其使用方法。
-
6.
公开(公告)号:US20140315199A1
公开(公告)日:2014-10-23
申请号:US14214300
申请日:2014-03-14
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Daniel RHODES , Seth Sadis , Peter Wyngaard , Nikolay Khazanov , Santhoshi Bandla , Mark Tomilo , Sean Eddy , Emma Bowden
IPC: C12Q1/68
Abstract: The disclosure provides gene fusions, gene variants, and novel associations with disease states, as well as kits, probes, and methods of using the same.
Abstract translation: 本公开提供了基因融合,基因变体和与疾病状态的新型关联,以及试剂盒,探针和使用它们的方法。
-
公开(公告)号:US11746379B2
公开(公告)日:2023-09-05
申请号:US16103516
申请日:2018-08-14
Applicant: Life Technologies Corporation
Inventor: Daniel Rhodes , Seth Sadis , Peter Wyngaard , Nikolay Khazanov , Santhoshi Bandla , Mark Tomilo , Sean Eddy , Emma Bowden , Jia Li
IPC: C12Q1/6886 , G16B20/20 , G16B20/00 , G16B30/00 , G16B40/00
CPC classification number: C12Q1/6886 , G16B20/20 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16 , G16B20/00 , G16B30/00 , G16B40/00
Abstract: The disclosure provides gene fusions, gene variants, and novel associations with disease states, as well as kits, probes, and methods of using the same.
-
公开(公告)号:US20230227919A1
公开(公告)日:2023-07-20
申请号:US18158732
申请日:2023-01-24
Applicant: Life Technologies Corporation
Inventor: Daniel Rhodes , Seth Sadis , Peter Wyngaard , Nikolay Khazanov , Santhoshi Bandla , Mark Tomilo , Sean Eddy , Emma Bowden , Jia Li
IPC: C12Q1/6886 , G16B20/20
CPC classification number: C12Q1/6886 , G16B20/20 , C12Q2600/16 , G16B20/00
Abstract: The disclosure provides gene fusions, gene variants, and novel associations with disease states, as well as kits, probes, and methods of using the same.
-
公开(公告)号:US11208690B2
公开(公告)日:2021-12-28
申请号:US16579652
申请日:2019-09-23
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Seth Sadis , Paul Williams
IPC: C12Q1/6886 , C12Q1/686
Abstract: Methods for predicting clinical outcome for a human subject diagnosed with squamous cell lung carcinoma using a panel of molecular markers that includes CDKN2A and CCND1. The markers are related to the subject's increased likelihood of a negative clinical outcome.
-
公开(公告)号:US10421994B2
公开(公告)日:2019-09-24
申请号:US15948908
申请日:2018-04-09
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Seth Sadis , Paul Williams
IPC: C12Q1/6886 , C12Q1/686
Abstract: Methods for predicting clinical outcome for a human subject diagnosed with squamous cell lung carcinoma using a panel of molecular markers that includes CDKN2A and CCND1. The markers are related to the subject's increased likelihood of a negative clinical outcome.
-
-
-
-
-
-
-
-
-